← Back to news
Y

Yahoo Finance

NVDA Earnings, FOMC and Other Key Things to Watch this Week

Y

This is the most affordable city in the US

Y

Walmart’s E-Commerce Surge: Can Digital Growth Offset Rising Cost Pressures in Q3?

Y

Bitcoin Approaches 'Death Cross' as Market Tests Major Historical Pattern

Y

Tesla Stock Hit This Record Right Before Its Slide

Y

500 Billion Reasons to Buy Nvidia Stock Like There's No Tomorrow

Y

Popular pasta chain closing dozens of restaurants

Y

The Hidden Fee in Mutual Funds That Eats Away at Your Returns

Y

401(k) hardship withdrawals more than double as people raid their retirement savings for emergencies

Y

Eli Lilly and Novo Nordisk May Soon Sell Weight Loss Drugs on the Planned TrumpRx. Could This Further Boost the Healthcare Giants' Stocks?

Y

I’m 51, married and pay $200 a month for a $1.5 million term life insurance policy. When should I cancel it?

Y

What We Lose With Remote Work—and How to Minimize the Damage

Y

1 No-Brainer Dividend ETF to Buy Right Now for Less Than $1,000

Y

Shein takes on key Amazon product line

Y

Prediction: This Will Be Wall Street's Next Trillion-Dollar Stock

Y

Google CEO Responds to Polymarket Bet: Are Prediction Markets Vulnerable To Celebrity Manipulation?

Y

The Best Cryptocurrency to Buy with $100 Right Now

Y

Best Stock to Buy Right Now: Costco vs. Coca-Cola

Y

Fed Minutes, Plus Walmart, Target, Home Depot, Nvidia, and More Stocks to Watch This Week

Y

Sealed Air (SEE) Climbs 18% on Takeover Bid

Y

Clearwater (CWAN) Jumps 19% as Firms Eye Takeover

Y

On Holding (ONON) Surges 21% on Earnings Blowout, Upbeat Outlook

Y

Ondas Holdings (ONDS) Climbs 23% on Bullish Outlook, Q3 Blowout

Y

Opendoor (OPEN) Soars 24% Ahead of Dividends

Y

Baytex (BTE) Climbs 25%, Extends 8-Day Run on Bullish Rating

Y

Avadel (AVDL) Gets 26% Boost on Takeover Bid

Y

Scholar Rock (SRRK) Soars 29% as Drug Candidate Progresses

Y

Cidara (CDTX) Climbs 105% on $9.2-Billion Merger with Merck

Y

Cogent Biosciences (COGT) Soars 126% on Stomach Cancer Treatment Progress

Y

Opendoor Stock Is Climbing Again: Value Trap or Amazing Opportunity?

Y

5 Ways the Upper-Middle Class Can Take Control of Their Finances in 2026

Y

3 Risks That Could Derail Krispy Kreme's Turnaround

Y

Cardano Avoids a Breakdown, Now Looks Ready To ‘Squeeze’ Out A Bounce

Y

2 Overvalued Stocks to Consider Selling Before It's Too Late

Y

3 Supercharged Growth Stocks That Billionaires Are Buying

Y

Charlie Javice Faces Accusations Of Billing JPMorgan For Personal Expenses Amid $74M Legal Claim

Y

‘Hold your ground’: Wall Street strategists say tech stock sell-off is a short-term blip as earnings bull case remains intact

Y

Better Artificial Intelligence Stock: IonQ vs. D-Wave Quantum

Y

4 Bank Accounts That Will Give You Free Money

Y

4 Cold-Weather Stocks to Buy as Winter Spending Heats Up

Y

Forget Nvidia: This Quantum Stock Is Poised for Explosive 10-Year Growth

Y

Is Oklo a Millionaire-Maker Stock?

Y

Costco’s (COST) Been A Disappointment but I’d Never Sell It, Says Jim Cramer

Y

Lam Research’s (LRCX) Going to “Have Orders as Far as the Eye Can See,” Says Jim Cramer

Y

Poorly Run CarMax (KMX) “Misjudged” The Market, Says Jim Cramer

Y

Intuit’s (INTU) Brand New Program Hasn’t Done Anything for the Stock, Says Jim Cramer

Y

Forget SCHD: These Dividend ETFs Are Better for Retirees

Y

Ripple’s RLUSD Stablecoin: A New Catalyst for XRP?

Y

The Best Way to Do a Roth IRA Conversion Before Retirement

Y

Car repossessions expected to hit their highest rate since the 2009 recession. Is it a sign the economy is in trouble?

Y